K. Wolff

Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).

M. Neurath, A. Hagel, R. Hofheinz, 2017, Anticancer research.

Granulomatous Lung Disease Requiring Mechanical Ventilation Induced by a Single Application of Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Case Report

M. Neurath, W. Hohenberger, R. Janka, 2013, Case reports in oncological medicine.

The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents

M. Beckmann, M. Neurath, M. Fromm, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An aid to the selection of chemotherapy regimens for oral cavity carcinomas. Early results of a study of 5-year survival based on antioncogram selection of anti-cancer drugs.

S. Jonas, H. Metelmann, S. Schlesinger, 1990, International journal of oral and maxillofacial surgery.

Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial

W. Hohenberger, E. Hahn, T. Horbach, 2009, Anti-cancer drugs.

Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsi

M. Neurath, W. Hohenberger, E. Hahn, 2011, Medical science monitor : international medical journal of experimental and clinical research.

A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results

M. Uder, R. Grützmann, M. Neurath, 2021, Oncology.

Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)

M. Neurath, W. Hohenberger, E. Hahn, 2011, Case Reports in Oncology.

Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option

M. Neurath, A. Hagel, R. Goertz, 2016, Case Reports in Oncology.

Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial

W. Hohenberger, E. Hahn, T. Horbach, 2009, Anti-cancer drugs.